Log in
Enquire now
‌

US Patent 8735539 Relaxin polypeptides comprising non-naturally encoded amino acids

Patent 8735539 was granted and assigned to Ambrx on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Ambrx
Ambrx
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8735539
Date of Patent
May 27, 2014
Patent Application Number
13212101
Date Filed
August 17, 2011
Patent Citations Received
‌
US Patent 11786578 Modified relaxin polypeptides and their uses
‌
US Patent 11865160 Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
0
Patent Primary Examiner
‌
Christine J. Saoud
Patent abstract

Modified relaxin polypeptides and their uses are provided. In one aspect, the disclosure provides a relaxin polypeptide comprising one or more non-naturally encoded amino acids. The polypeptide may be linked to a linker, polymer, or biologically active molecule. The serum half-life of the relaxin polypeptide may be enhanced relative to the unconjugated form. In another aspect, the disclosure provides methods of treating a patient having a disorder modulated by relaxin.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8735539 Relaxin polypeptides comprising non-naturally encoded amino acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.